POST-BARIATRIC HYPOGLYCEMIA
Clinical trials for POST-BARIATRIC HYPOGLYCEMIA explained in plain language.
Never miss a new study
Get alerted when new POST-BARIATRIC HYPOGLYCEMIA trials appear
Sign up with your email to follow new studies for POST-BARIATRIC HYPOGLYCEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for dangerous sugar crashes after gastric bypass
Disease control OngoingThis study tests a drug called pasireotide to help people who have dangerously low blood sugar after weight-loss surgery. About 93 adults will receive either the drug or a placebo for 12 weeks, then everyone can get the drug for another 36 weeks. The goal is to see if pasireotide…
Matched conditions: POST-BARIATRIC HYPOGLYCEMIA
Phase: PHASE2 • Sponsor: RECORDATI GROUP • Aim: Disease control
Last updated May 26, 2026 07:21 UTC
-
New hope for dangerous blood sugar drops after gastric bypass
Disease control OngoingThis study tests a drug called avexitide in 75 adults who have severe low blood sugar episodes after gastric bypass surgery. The goal is to see if the drug can reduce these dangerous events compared to a placebo. Participants will be monitored for 16 weeks, with an option to cont…
Matched conditions: POST-BARIATRIC HYPOGLYCEMIA
Phase: PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control
Last updated May 08, 2026 12:00 UTC